3 results

• Actos Bladder Cancer Warnings Updated by FDA to Add New Study Data Reviewed

  December 13, 2016

  Irvin Jackson

  The FDA has updated Actos label warnings with additional study information and reinforced its belief that the diabetes drug's side effects may increase the risk of bladder cancer.

• Heart Failure Risk with Onglyza, Similar Diabetes Drugs Lead to FDA Warnings

  April 6, 2016

  Austin Kirk

  Onglyza and similar diabetes drugs may increase the risk of heart failure, according to an FDA warning that will lead to new label warnings being added to the drugs.

• Amid Actos Suits and Declined Sales, Takeda Pushes New Diabetes Drug

  January 29, 2013

  Irvin Jackson

  As sales of the brand-name version of the diabetes drug Actos continue fall amid mounting injury lawsuits and recent generic...